PTJ
ITOS

Paul Tudor Jones’s iTeos Therapeutics ITOS Stock Holding History

Paul Tudor Jones’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15,415
Closed -$154K – 3610
2025
Q2 		$154K Sell
15,415
-2,236
-13% -$18K ﹤0.01% 3129
2025
Q1 		$105K Buy
+17,651
New +$130K ﹤0.01% 2939
2024
Q4 		– Sell
-11,649
Closed -$119K – 3261
2024
Q3 		$119K Buy
+11,649
New +$178K ﹤0.01% 2583
2024
Q2 		– Sell
-17,635
Closed -$241K – 2545
2024
Q1 		$241K Hold
17,635
– – ﹤0.01% 1952
2023
Q4 		$193K Hold
17,635
– – ﹤0.01% 2210
2023
Q3 		$193K Buy
17,635
+3
+0% +$38 ﹤0.01% 2101
2023
Q2 		$233K Sell
17,632
-40
-0.2% -$570 ﹤0.01% 2145
2023
Q1 		$241K Sell
17,672
-58
-0.3% -$1.04K ﹤0.01% 2073
2022
Q4 		$346K Buy
+17,730
New +$346K 0.01% 1810
2021
Q3 		– Sell
-25,485
Closed -$654K – 2626
2021
Q2 		$654K Buy
+25,485
New +$607K 0.01% 1062

Other funds holding ITOS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Paul Tudor Jones's ITOS Position: Q3 2025 in Review

Paul Tudor Jones sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 15,415 shares — an estimated $154K sold.

Paul Tudor Jones first reported a position in ITOS in Q2 2021 and held it in 10 quarters. The position peaked at $654K in Q2 2021. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

  • Paul Tudor Jones reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Paul Tudor Jones sold 15,415 iTeos Therapeutics shares in Q3 2025, an estimated $154K.
  • Paul Tudor Jones first reported a position in iTeos Therapeutics in Q2 2021 and held it in 10 quarters.
  • Paul Tudor Jones's iTeos Therapeutics position peaked at $654K in Q2 2021.
  • 1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Tudor Investment Corp's 13F filing for Q3 2025, filed 14 Nov 2025.